Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial

Timothy S. Maughan, Richard A. Adams, Christopher G. Smith, Angela M. Meade, Matthew T. Seymour, Richard H. Wilson, Shelley Idziaszczyk, Rebecca Harris, David Fisher, Sarah L. Kenny, Edward Kay, Jenna K. Mitchell, Ayman Madi, Bharat Jasani, Michelle D. James, John Bridgewater, M. John Kennedy, Bart Claes, Diether Lambrechts, Richard KaplanJeremy P. Cheadle

Research output: Contribution to journalArticlepeer-review

726 Citations (Scopus)

Fingerprint Dive into the research topics of 'Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial'. Together they form a unique fingerprint.

Medicine & Life Sciences